Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers.
Bocchi EA, Moreira HT, Nakamuta JS, Simões MV; CLIMB-HF Study Group; Casas AAL, Costa ARD, Assis AV, Durães AR, Pereira-Barretto AC, Ravessa ADA, Macedo AVS, Biselli B, Pinto CMN, Filho CRH, Costantini CR, Almeida DR, Santos EGD Jr, Soliva Junior E, Figueiredo EL, Albuquerque FN, Paulitsch F, Neuenschwander FC, Figueiredo Neto JA, Brito FS, Lopes HF, Villacorta H, Souza Neto JD, Sepulveda JM, Ayoub JCA, Vilela-Martin JF, Cardoso JN, Uemura L, Moura LZ, Maia LN, Oliveira LB, Maia L, Silva LBD, Gowdak LHW, Danzmann LC, Andrade M, Braile-Sternieri MCVB, Moreira MDCV, França Neto OR, Filho ORC, Esteves PF, Raupp-da-Rosa P, Silva RJQE, Mourilhe-Rocha R, Viégas RFM, Rassi S, Mangili S, Kaiser SE, Martins SM, Kawabata VS.
Bocchi EA, et al.
Clinics (Sao Paulo). 2021 Jan 20;76:e1991. doi: 10.6061/clinics/2021/e1991. eCollection 2021.
Clinics (Sao Paulo). 2021.
PMID: 33503176
Free PMC article.
Physicians considered changing or introducing new medications mostly when patients were hospitalized or when observing worsening disease and/or symptoms. Adherence to drug treatment and non-drug treatment factors were the greatest medical problems associated with HF …
Physicians considered changing or introducing new medications mostly when patients were hospitalized or when observing worsening disease and …
